Godavari Drugs (BOM:530317) ROCE % : 24.61% (As of Dec. 2023)

View and export this data going back to 2001. Start your Free Trial

What is Godavari Drugs ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Godavari Drugs's annualized ROCE % for the quarter that ended in Dec. 2023 was 24.61%.

Godavari Drugs ROCE % Historical Data

The historical data trend for Godavari Drugs's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Godavari Drugs ROCE % Chart

Godavari Drugs Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

ROCE %

Get a 7-Day Free Trial

14.61

14.08

21.41

20.65

17.07

Godavari Drugs Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROCE %	Get a 7-Day Free Trial															18.29	12.68	18.67	20.99	24.61

Godavari Drugs ROCE % Calculation

Godavari Drugs's annualized ROCE % for the fiscal year that ended in Mar. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Mar. 2023 )		(A: Mar. 2022 )		(A: Mar. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Mar. 2023 )		(A: Mar. 2022 )		(A: Mar. 2023 )
	=	78.005	/	( ( (1014.11 - 577.609)	+	(1214.33 - 737.081) )	/ 2 )
	=	78.005	/	( (436.501	+	477.249)	/ 2 )
	=	78.005	/	456.875
	=	17.07 %

Godavari Drugs's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	120.64	/	( ( (1271.684 - 781.498)	+	(0 - 0) )	/ 1 )
	=	120.64	/	( ( 490.186	+	0 )	/ 1 )
	=	120.64	/	490.186
	=	24.61 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

Godavari Drugs (BOM:530317) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Godavari Drugs ROCE % Related Terms

Thank you for viewing the detailed overview of Godavari Drugs's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Godavari Drugs (BOM:530317) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Godavari Drugs Ltd (BOM:530317) » Definitions » ROCE %

Traded in Other Exchanges

N/A

Address

Sardar Patel Road, 1-8-303/34, Mayfair, 1st Floor, Secunderabad, TG, IND, 500 003

Website

https://www.godavaridrugs.com

Godavari Drugs Ltd is an India-based pharmaceutical company. It is principally engaged in the business activity of manufacturing pharmaceutical drugs. The firm's product includes Ciprofloxacin Lactate IH, A D Lactone, Ciprofloxacin Betaine, Enrofloxacin USP/EP/BP/IP, and Others. The company operates only one segment which is the manufacture and sale of Active Pharmaceutical Ingredients (API) and its intermediates.

Godavari Drugs (BOM:530317) Headlines

No Headlines